Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI. (Q37091605)

From Wikidata

Jump to navigation Jump to search

scientific article published on April 2016

Language	Label	Description	Also known as
English	Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI.	scientific article published on April 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Intravenous Tigecycline Facilitates Cure of Severe Clostridium difficile Infection (CDI) After Failure of Standard Therapy: A Case Report and Literature Review of Tigecycline Use in CDI. (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Clostridium difficile

0 references

author name string

Bhagyashri D Navalkele

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Stephen A Lerner

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2016

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Open Forum Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ofw094

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

4 November 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Recurrent refractory Clostridium difficile colitis treated successfully with rifaximin and tigecycline: a case report and review of the literature.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Failure of tigecycline to treat severe Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

New advances in the treatment of Clostridium difficile infection (CDI)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Effect of tigecycline on normal oropharyngeal and intestinal microflora

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Tigecycline: a critical analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

29 September 2017

Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

27 June 2018

Tigecycline for severe Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

3 September 2018

Refractory Clostridium difficile Infection Successfully Treated with Tigecycline, Rifaximin, and Vancomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

3 September 2018

Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4943546

3 September 2018

Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update

1 reference

https://pubmed.ncbi.nlm.nih.gov/27419166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous tigecycline in the treatment of severe recurrent Clostridium difficile colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27419166

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/OFID/OFW094

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37091605&oldid=2174449057"